Two athletes stand on a DEXA scanner. Both read 18% body fat. Both look fit. Their cardiometabolic risk profiles are completely different. The reason: one stores fat predominantly in the abdomen; the other in the hips and thighs.
The distinction between android (abdominal) and gynoid (lower-body) fat distribution is one of the most important — and most overlooked — dimensions of body composition assessment for athletic health. A single body fat percentage number tells you nothing about where that fat resides, and fat location is far more predictive of metabolic disease risk than total fat mass.
---
The Anatomy: Visceral vs Subcutaneous Fat
Android fat distribution is characterised by predominant adipose deposition in the abdominal region, and critically, a higher proportion of visceral adipose tissue (VAT) — fat stored within the abdominal cavity surrounding the organs (omentum, mesenteric fat, perivisceral fat).
Gynoid fat distribution features predominant deposition in the hips, buttocks, and thighs, almost entirely as subcutaneous adipose tissue (SCAT) — fat stored beneath the skin layer, separated from visceral organs by the fascial planes.
These two depot types are not simply the same tissue stored in different locations. They differ fundamentally in metabolic behaviour, inflammatory output, and hormonal activity.
---
Why Visceral Fat Is Metabolically Active and Dangerous
Visceral adipocytes are highly lipolytic — they release free fatty acids (FFA) rapidly in response to catecholamine stimulation. The anatomical consequence is critical: FFA from visceral fat drains directly into the portal vein, delivering a high-flux fatty acid load to the liver. This hepatic lipotoxicity drives de novo lipogenesis, VLDL overproduction, dyslipidaemia, and non-alcoholic fatty liver disease (NAFLD) — independent of total body fat.
Beyond FFA release, visceral adipocytes are major secretors of pro-inflammatory adipokines: TNF-α, IL-6, and resistin are released in higher quantities from VAT than from subcutaneous depots. These adipokines promote systemic low-grade inflammation, impair insulin signalling (insulin resistance via IRS-1 serine phosphorylation), and have direct cardiovascular effects including endothelial dysfunction.
In contrast, subcutaneous fat — the dominant depot in gynoid distribution — secretes higher amounts of adiponectin, an insulin-sensitising, anti-inflammatory adipokine. Gluteofemoral SCAT is effectively a metabolically protective depot, a long-term fatty acid storage reservoir that is slow to release FFA and does not contribute to portal lipotoxicity.
Karpe and Pinnick (2015, Nature Reviews Endocrinology) elegantly summarised this dichotomy: "Gluteofemoral fat is your friend; visceral fat is your enemy."
---
The Waist-to-Hip Ratio: A Simple Proxy
The most accessible clinical proxy for fat distribution pattern is the waist-to-hip ratio (WHR). WHR above 0.90 in men and above 0.85 in women is classified as android distribution by WHO criteria, associated with significantly elevated cardiometabolic risk independent of BMI or total body fat.
The waist circumference alone is also highly predictive: >102cm in men and >88cm in women (NIH/ATP III criteria) identifies high-risk abdominal adiposity. Some researchers argue that waist circumference is the single most practically powerful anthropometric predictor of type 2 diabetes risk — more powerful than BMI, body fat percentage, or waist-hip ratio in isolation (Yusuf et al., INTERHEART study, 2005, Lancet).
For athletes, these thresholds are unlikely to be reached during active training. The concern arises in off-season periods, after retirement, or during extended injury-imposed inactivity — when fat redistribution can occur without detectable changes in total body weight.
---
Exercise, Fat Distribution, and the Training Dividend
Endurance training preferentially mobilises visceral fat. Aerobic exercise upregulates β-adrenergic receptor sensitivity in visceral adipocytes, making them more responsive to catecholamine-driven lipolysis during exercise. Multiple systematic reviews confirm that aerobic training reduces VAT independent of total fat mass changes — with CT-measured VAT reduction often exceeding 10–15% from exercise alone.
Strength training also reduces VAT, via increased resting metabolic rate, testosterone-mediated adipose redistribution, and GLUT4-mediated insulin sensitivity improvements in muscle. The combined effect of concurrent training (aerobic + resistance) on VAT reduction is consistently superior to either modality alone.
For athletes monitoring their body composition, the location and type of adipose tissue is as important as the total percentage. A DEXA scan reporting an android:gynoid ratio, or simple waist circumference tracking, provides far more actionable health information than a body fat percentage alone.
---
Athletes who want to go beyond body fat percentage and assess their body composition from a distribution and health-risk perspective can use the free tool at winsport.uk/tools/strength/body-fat-calculator, which includes waist and hip circumference inputs to estimate fat distribution pattern alongside total fat percentage.
Do you track your waist circumference alongside body weight and body fat percentage as a health metric?